Evotec SE (EVO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.38, -2.82% vs the prior close of $1.42.
- Volume 82.40K shares, 0.7x its 50-day average.
- New SEC filings: 6-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
EVO dips 2.8% to $1.38. Closed at $1.38, -2.82% vs the prior close of $1.42. Day range $1.38–$1.43, opened at $1.43.
EVO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — EVO dips 2.8% to $1.38
- Closed at $1.38, -2.82% vs the prior close of $1.42. Day range $1.38–$1.43, opened at $1.43.
- Volume was 82.40K shares, 0.7x its 50-day average of 111.72K.
- Price is -20.9% vs its 50-day average ($1.75) and -47.3% vs its 200-day average ($2.62).
- 52-week range $1.33–$4.27; today's close sits at 2% of that range, 67.7% below the 52-week high.
Oct 15, 2026 — EVO dips 0.7% to $1.42
- Closed at $1.42, -0.70% vs the prior close of $1.43. Day range $1.39–$1.44, opened at $1.44.
- Volume was 124.00K shares, 1.0x its 50-day average of 118.34K.
- Price is -19.2% vs its 50-day average ($1.76) and -46.0% vs its 200-day average ($2.63).
- 52-week range $1.33–$4.27; today's close sits at 3% of that range, 66.7% below the 52-week high.
- SEC filings that day: 6-K.
Oct 14, 2026 — EVO jumps 5.9% to $1.43
- Closed at $1.43, +5.93% vs the prior close of $1.35. Day range $1.41–$1.48, opened at $1.48.
- Volume was 158.40K shares, 1.4x its 50-day average of 115.50K.
- Price is -19.1% vs its 50-day average ($1.77) and -45.8% vs its 200-day average ($2.64).
- 52-week range $1.33–$4.27; today's close sits at 3% of that range, 66.5% below the 52-week high.
- SEC filings that day: 6-K.
Oct 13, 2026 — EVO dips 1.5% to $1.35, a 52-week low, 6 down days in a row
- Closed at $1.35, -1.46% vs the prior close of $1.37. Day range $1.33–$1.35, opened at $1.35.
- Volume was 113.70K shares, 1.0x its 50-day average of 114.80K.
- Price is -24.1% vs its 50-day average ($1.78) and -49.0% vs its 200-day average ($2.65).
- 52-week range $1.33–$4.27; today's close sits at 1% of that range, 68.4% below the 52-week high.
- That makes 6 straight losses.
Oct 12, 2026 — EVO slides 10.5% to $1.37, a 52-week low, 5 down days in a row
- Closed at $1.37, -10.46% vs the prior close of $1.53. Day range $1.36–$1.44, opened at $1.44.
- Volume was 182.60K shares, 1.6x its 50-day average of 111.83K.
- Price is -23.5% vs its 50-day average ($1.79) and -48.4% vs its 200-day average ($2.65).
- 52-week range $1.36–$4.27; today's close sits at 0% of that range, 67.9% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — EVO dips 2.5% to $1.53, 4 down days in a row
- Closed at $1.53, -2.55% vs the prior close of $1.57. Day range $1.53–$1.57, opened at $1.56.
- Volume was 40.00K shares, 0.4x its 50-day average of 111.91K — lighter than usual.
- Price is -15.0% vs its 50-day average ($1.80) and -42.5% vs its 200-day average ($2.66).
- 52-week range $1.50–$4.27; today's close sits at 1% of that range, 64.2% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — EVO dips 2.5% to $1.57, 3 down days in a row
- Closed at $1.57, -2.48% vs the prior close of $1.61. Day range $1.53–$1.60, opened at $1.59.
- Volume was 94.40K shares, 0.8x its 50-day average of 111.48K.
- Price is -13.2% vs its 50-day average ($1.81) and -41.2% vs its 200-day average ($2.67).
- 52-week range $1.50–$4.27; today's close sits at 3% of that range, 63.2% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — EVO dips 1.2% to $1.61
- Closed at $1.61, -1.23% vs the prior close of $1.63. Day range $1.58–$1.63, opened at $1.60.
- Volume was 93.10K shares, 0.8x its 50-day average of 110.62K.
- Price is -11.4% vs its 50-day average ($1.82) and -39.9% vs its 200-day average ($2.68).
- 52-week range $1.50–$4.27; today's close sits at 4% of that range, 62.3% below the 52-week high.
Oct 6, 2026 — EVO dips 1.8% to $1.63
- Closed at $1.63, -1.81% vs the prior close of $1.66. Day range $1.61–$1.73, opened at $1.73.
- Volume was 193.80K shares, 1.8x its 50-day average of 108.87K.
- Price is -10.6% vs its 50-day average ($1.82) and -39.3% vs its 200-day average ($2.68).
- 52-week range $1.50–$4.27; today's close sits at 5% of that range, 61.8% below the 52-week high.
Oct 5, 2026 — EVO jumps 3.7% to $1.66 on 3.3x normal volume
- Closed at $1.66, +3.75% vs the prior close of $1.60. Day range $1.61–$1.73, opened at $1.61.
- Volume was 342.00K shares, 3.3x its 50-day average of 102.71K — unusually heavy trading.
- Price is -9.2% vs its 50-day average ($1.83) and -38.3% vs its 200-day average ($2.69).
- 52-week range $1.50–$4.27; today's close sits at 6% of that range, 61.1% below the 52-week high.
Oct 2, 2026 — EVO slides 3.0% to $1.60
- Closed at $1.60, -3.03% vs the prior close of $1.65. Day range $1.59–$1.63, opened at $1.63.
- Volume was 52.00K shares, 0.5x its 50-day average of 102.60K — lighter than usual.
- Price is -12.8% vs its 50-day average ($1.83) and -40.7% vs its 200-day average ($2.70).
- 52-week range $1.50–$4.27; today's close sits at 4% of that range, 62.5% below the 52-week high.
EVO latest news & SEC filings
Every SEC filing by or about EVO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 14, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade EVO
- How much it moves: over the last 20 sessions the average daily move was 3.03% (largest 10.5%). That is a volatile stock.
- Liquidity: about 143.99K shares (≈$198.71K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.38 vs a range of $1.33–$4.27 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 15, 2026; 6-K Oct 14, 2026; 6-K Sep 29, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
EVO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.43 | 1.43 | 1.38 | 1.38 | 82.40K |
| Oct 15, 2026 | 1.44 | 1.44 | 1.39 | 1.42 | 124.00K |
| Oct 14, 2026 | 1.48 | 1.48 | 1.41 | 1.43 | 158.40K |
| Oct 13, 2026 | 1.35 | 1.35 | 1.33 | 1.35 | 113.70K |
| Oct 12, 2026 | 1.44 | 1.44 | 1.36 | 1.37 | 182.60K |
| Oct 9, 2026 | 1.56 | 1.57 | 1.53 | 1.53 | 40.00K |
| Oct 8, 2026 | 1.59 | 1.60 | 1.53 | 1.57 | 94.40K |
| Oct 7, 2026 | 1.60 | 1.63 | 1.58 | 1.61 | 93.10K |
| Oct 6, 2026 | 1.73 | 1.73 | 1.61 | 1.63 | 193.80K |
| Oct 5, 2026 | 1.61 | 1.73 | 1.61 | 1.66 | 342.00K |
| Oct 2, 2026 | 1.63 | 1.63 | 1.59 | 1.60 | 52.00K |
| Oct 1, 2026 | 1.69 | 1.70 | 1.65 | 1.65 | 119.00K |
| Sep 30, 2026 | 1.70 | 1.71 | 1.69 | 1.71 | 101.60K |
| Sep 29, 2026 | 1.60 | 1.64 | 1.60 | 1.64 | 94.90K |
| Sep 28, 2026 | 1.56 | 1.59 | 1.56 | 1.59 | 187.80K |
| Sep 25, 2026 | 1.54 | 1.56 | 1.52 | 1.56 | 20.50K |
| Sep 24, 2026 | 1.52 | 1.54 | 1.51 | 1.53 | 29.80K |
| Sep 23, 2026 | 1.55 | 1.56 | 1.53 | 1.54 | 37.20K |
| Sep 22, 2026 | 1.55 | 1.58 | 1.53 | 1.58 | 126.90K |
| Sep 21, 2026 | 1.62 | 1.63 | 1.50 | 1.54 | 685.70K |
About Evotec SE
Evotec SE (EVO) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in HAMBURG. State of incorporation: Germany. Fiscal year ends December 31. SEC CIK 1412558.
EVO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
EVO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
EVO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on EVO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.